Insulin-like Growth Factor (IGF) -II, Cytotrophoblast Migration And Placental Development
Funder
National Health and Medical Research Council
Funding Amount
$487,750.00
Summary
During pregnancy, placental cells invade into the uterus and tap into the maternal blood vessels to procure an adequate blood supply for the growth of the placenta and hence the fetus. If this invasion process is impaired early in pregnancy, then the woman may suffer a miscarriage, if the process is impaired in mid-pregnancy then the mother may develop preeclampsia in which her blood pressure goes up and, in severe cases, placing her life and that of her unborn baby at risk. Miscarriage occurs i ....During pregnancy, placental cells invade into the uterus and tap into the maternal blood vessels to procure an adequate blood supply for the growth of the placenta and hence the fetus. If this invasion process is impaired early in pregnancy, then the woman may suffer a miscarriage, if the process is impaired in mid-pregnancy then the mother may develop preeclampsia in which her blood pressure goes up and, in severe cases, placing her life and that of her unborn baby at risk. Miscarriage occurs in 10-15% of pregnancies and preecclampsia in 7% of pregnancies. Preecclampsia may be life-threatening in up to 3% of all pregnancies and is a major cause of maternal death in pregnant women in Western countries. This project will examine the effect of treatment of the pregnant guinea pig with insulin-like growth factor-II on placental cell invasion and the capacity of the placenta to deliver nutrients to the fetus. We will also determine whether the effects of this treatment are mediated by a specific membrane receptor on the cell surface of the invading placental cells. We predict that this growth factor will enhance placental cell invasion and improve placental function. If this is the case then our findings may be developed for use in women at risk, to improve placental function and hence maternal and fetal health.Read moreRead less
Diagnostic Tests To Predict Risk For Life Threatening Pregnancy Complications
Funder
National Health and Medical Research Council
Funding Amount
$682,824.00
Summary
The main complications of pregnancy, preeclampsia, preterm birth and intrauterine growth restriction afflict 19% of first pregnancies and are life threatening to the mother or baby in 6% of pregnancies. Currently we have no way of knowing which women will suffer these diseases until symptoms manifest. We aim to develop genetic tests that can predict which women are at risk. This will permit earlier interventions that will improve the health of pregnant women and their babies.
Antenatal Insulin-like Growth Factor-I And Perinatal Growth, Survival And Function Of The Growth Restricted Fetus.
Funder
National Health and Medical Research Council
Funding Amount
$150,370.00
Summary
Poor growth before birth or intrauterine growth restriction (IUGR), as indicated by being light, short or thin for stage of pregnancy, greatly increases the risk of illness and death before and after birth and in infancy. IUGR has increased risks of asphyxia, poor glucose control, hypothermia, respiratory difficulties, neurological problems and poor immune function, many of which persist. IUGR is one of the most common clinical problems in obstetrics and neonatology, with ~6% of infants born IUG ....Poor growth before birth or intrauterine growth restriction (IUGR), as indicated by being light, short or thin for stage of pregnancy, greatly increases the risk of illness and death before and after birth and in infancy. IUGR has increased risks of asphyxia, poor glucose control, hypothermia, respiratory difficulties, neurological problems and poor immune function, many of which persist. IUGR is one of the most common clinical problems in obstetrics and neonatology, with ~6% of infants born IUGR in Australia in non-Aboriginal communities and between 7 to 17% in Aboriginal communities. Despite these adverse consequences for health of the individual throughout life, we do not currently have any effective therapies to treat IUGR. Small infants are mostly a result of an inadequate supply of oxygen and nutrients before birth, due to an impaired capacity of the mother to acquire these for the placenta to deliver them to the growing fetus or due to poor functioning of the placenta itself. This intrauterine malnutrition not only slows growth, but impairs the development of a range of body functions leading to the increased risk of illness and death in IUGR. Therapies to be used before birth to treat IUGR need to either restore supply of oxygen and nutrients or to promote growth and functional development. We have discovered that administration of a major growth promoting hormone, insulin-like growth factor-I (IGF-I), to the IUGR fetus, which has low levels of IGF-I, increases its growth. This project will therefore determine if directly giving this hormone in the IUGR fetus will restore development as well as growth before birth, improving function and hence survival and health after birth. If successful, the first effective approach to the antenatal treatment of IUGR will have been identified and would provide the essential knowledge for the design of a range of therapies to best restore the abundance of IGF within the IUGR fetus to improve perinatal and later outcomes.Read moreRead less
Adults who were small at birth have a higher risk of coronary heart disease and adult onset diabetes. From a public health point of view the most important issue is to identify which factors in pregnancy cause low birthweight and lead to increased risk of adult disease. Growth of a fetus depends on the supply of oxygen and nutrients and the availability of nutrients will depend on both the mother's dietary intake and the transfer of nutrients, via the placenta, to the baby It is important that w ....Adults who were small at birth have a higher risk of coronary heart disease and adult onset diabetes. From a public health point of view the most important issue is to identify which factors in pregnancy cause low birthweight and lead to increased risk of adult disease. Growth of a fetus depends on the supply of oxygen and nutrients and the availability of nutrients will depend on both the mother's dietary intake and the transfer of nutrients, via the placenta, to the baby It is important that we understand the role of maternal nutrition in fetal growth because it is potentially modifiable. Although we know that birthweight falls in times of famine little is known about whether the composition of a mother's diet in a developed society affects birthweight and later health of the offspring. We plan to study this in twin pregnancies, since maternal nutrition is more stretched and any effects should be magnified and more readily identified. It may be that maternal nutrition only matters if the placenta is not working as well as it should. Unfortunately there is no good measure of how well the placenta is working, but we will measure erythropoietin level in infants as a marker of whether they were getting enough oxygen via the placenta, and see whether there is any evidence that maternal nutrition matters more as the infant shows more signs of poor oxygen supply. In twins we can look between pairs for evidence that maternal nutritional factors affect birthweight, at twins within pairs to see whether oxygen supply or other individual factors are important and we can compare all infants as individuals to see how these different factors interact. We plan to study 200 women with twin pregnancies in Melbourne and Adelaide. Once we have identified factors influencing birthweight, we will be in a position to plan future studies to determine which are associated with increased risk markers for cardiovascular diseaseRead moreRead less